We are live on ! Find out more
CVG

Convergys
CVG

Delisted

CVG was delisted on the 4th of October, 2018.

208 hedge funds and large institutions have $1.85B invested in Convergys in 2013 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 67 increasing their positions, 86 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 14

6% more capital invested

Capital invested by funds: $1.75B → $1.85B (+$100M)

2% more funds holding

Funds holding: 203208 (+5)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

22% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 86

Holders
208
Holders Change
+5
Holders Change %
+2.46%
% of All Funds
6.74%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.13%
New
20
Increased
67
Reduced
86
Closed
14
Calls
$2K
Puts
Net Calls
+$2K
Net Calls Change
-$284K
Name Holding Trade Value Shares
Change
Change in
Stake
LIM
51
Lathrop Investment Management
Arkansas
$6.42M +$210K +11,220 +3%
NFA
52
Nationwide Fund Advisors
Ohio
$6.29M -$232K -12,392 -4%
Wells Fargo
53
Wells Fargo
California
$5.78M +$139K +7,402 +2%
Deutsche Bank
54
Deutsche Bank
Germany
$5.66M +$894K +47,732 +19%
Arrowstreet Capital
55
Arrowstreet Capital
Massachusetts
$5.47M -$5.54M -295,704 -50%
AIG
56
American International Group
New York
$5.35M -$140K -7,485 -3%
New York State Teachers Retirement System (NYSTRS)
57
New York State Teachers Retirement System (NYSTRS)
New York
$4.96M -$157K -8,400 -3%
Principal Financial Group
58
Principal Financial Group
Iowa
$4.88M +$62.4K +3,331 +1%
RhumbLine Advisers
59
RhumbLine Advisers
Massachusetts
$4.55M -$112K -5,992 -2%
CEP
60
Chicago Equity Partners
Illinois
$4.45M -$86K -4,590 -2%
PI
61
Putnam Investments
Massachusetts
$4.35M -$809K -43,200 -16%
PPA
62
Parametric Portfolio Associates
Washington
$4.32M +$103K +5,473 +2%
D.E. Shaw & Co
63
D.E. Shaw & Co
New York
$4.1M +$371K +19,793 +10%
State of Tennessee, Department of Treasury
64
State of Tennessee, Department of Treasury
Tennessee
$3.94M +$3.93M +210,000 New
CBOA
65
Commonwealth Bank of Australia
Australia
$3.72M -$268K -14,299 -7%
California State Teachers Retirement System (CalSTRS)
66
California State Teachers Retirement System (CalSTRS)
California
$3.54M +$109K +5,794 +3%
Axa
67
Axa
France
$3.51M +$176K +9,400 +5%
PAM
68
Panagora Asset Management
Massachusetts
$3.27M -$357K -19,076 -10%
MLICM
69
Metropolitan Life Insurance Company (MetLife)
New York
$3.07M +$300 +16 +0%
CS
70
Credit Suisse
Switzerland
$2.94M -$1.16M -62,063 -28%
MAA
71
Managed Account Advisors
New Jersey
$2.87M +$770K +41,117 +37%
TA
72
Teachers Advisors
New York
$2.85M +$102K +5,460 +4%
U
73
UBS
Switzerland
$2.56M +$130K +6,947 +5%
MIU
74
Man Investments (UK)
United Kingdom
$2.54M +$2.54M +135,636 New
Retirement Systems of Alabama
75
Retirement Systems of Alabama
Alabama
$2.38M -$44.5K -2,378 -2%

CVG Hedge Fund Activity: Q3 2013 in Review

208 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Convergys (CVG) for Q3 2013, worth a combined $1.85B — up 5.7% from $1.75B a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new CVG positions and 14 closed out — a net gain of 6 holders — while 67 added to existing stakes and 86 trimmed.

The largest buyer was Fuller & Thaler Asset Management, adding an estimated $8.03M. The largest seller was AQR Capital Management, cutting an estimated $11.7M.

  • 208 institutional investors held Convergys (CVG) as of Q3 2013, up from 203 in Q2 2013.
  • Funds reported $1.85B of Convergys stock for Q3 2013, up 5.7% quarter-over-quarter.
  • 20 funds opened new Convergys positions in Q3 2013 and 14 closed out, a net change of +6 holders.
  • The largest Convergys buyer in Q3 2013 was Fuller & Thaler Asset Management, an estimated $8.03M added.
  • The largest Convergys seller in Q3 2013 was AQR Capital Management, an estimated $11.7M sold.

Based on aggregated 13F filings for Q3 2013.